President Trump
We Save Lives While Our Critics Complain
January 25, 2018In his first press conference as president-elect, Donald Trump insisted pharma was "getting away with murder" due to expensive drug prices.
How will the pharma industry fare in 2018 under Trump?
December 05, 2017The first year of the Trump administration was kind to pharma, but it might not be so fortunate in 2018.
Five things for pharma marketers to know: Monday, March 27, 2017
March 27, 2017Alexion names former Baxalta head as CEO; U.S. dollar drops after AHCA-fail; EMA advises suspension of 300 generic drugs by Indian drugmaker
Five things for pharma marketers to know: Friday, March 24, 2017
March 24, 2017Lilly to invest $850 million in the U.S.; President Trump gives GOP leaders ultimatum on healthcare bill; Pfizer, Merck KGaA receive FDA approval for Bavencio
New healthcare bill to negatively affect drugmakers: Moody's
March 17, 2017Per the credit ratings agency, more uninsured Americans will lead to less demand for healthcare services and treatments.
Five things for pharma marketers to know: Tuesday, March 14, 2017
March 14, 2017Pershing Square sells entire Valeant stake; FDA approves Novartis breast-cancer drug combo; Express Scripts asks Gilead to lower hep-C drug prices
Five things for pharma marketers to know: Friday, March 10, 2017
March 10, 2017Novartis' Gleevec shows long-term survival benefit in study; Novo Nordisk CEO considers small acquisitions; Merck KGaA to sell biosimilars unit
Five things for pharma marketers to know: Wednesday, January 25, 2017
January 25, 2017Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims
Five things for pharma marketers to know: Tuesday, January 24, 2017
January 24, 2017Endo settles pay-for-delay charges; Trump signs order withdrawing U.S. from TPP; administration considers Patrick Soon-Shiong for healthcare role
Healthcare communicators track Obamacare repeal debate
January 22, 2017Many healthcare comms leaders are paying close attention to the debate between "access" to healthcare versus making it a requirement, experts say.
